Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients.
Gottsäter A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G. Gottsäter A, et al. Acta Diabetol. 1994 Dec;31(4):226-31. doi: 10.1007/BF00571956. Acta Diabetol. 1994. PMID: 7888694
Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion.
Gottsäter A, Landin-Olsson M, Fernlund P, Gullberg B, Lernmark A, Sundkvist G. Gottsäter A, et al. Scand J Clin Lab Invest. 1992 Nov;52(7):631-9. doi: 10.3109/00365519209115506. Scand J Clin Lab Invest. 1992. PMID: 1455155
Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes.
Gottsäter A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G, Hagopian WA. Gottsäter A, et al. Diabetes Res Clin Pract. 1995 Feb;27(2):133-40. doi: 10.1016/0168-8227(95)01026-a. Diabetes Res Clin Pract. 1995. PMID: 7607051
Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden.
Clauson P, Linnarsson R, Gottsäter A, Sundkvist G, Grill V. Clauson P, et al. Among authors: gottsater a. Diabet Med. 1994 Oct;11(8):794-801. doi: 10.1111/j.1464-5491.1994.tb00355.x. Diabet Med. 1994. PMID: 7851075
To clarify whether metabolic control and beta-cell function deteriorate with increasing duration of diabetes, we investigated in a cross-sectional study Type 2 diabetic patients in an area-based population. ...
To clarify whether metabolic control and beta-cell function deteriorate with increasing duration of diabetes, we investigated in a cr …
Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G. Gottsäter A, et al. Diabetes Care. 1993 Jun;16(6):902-10. doi: 10.2337/diacare.16.6.902. Diabetes Care. 1993. PMID: 8325204
At diagnosis, type II diabetic patients with ICA showed a 1 + 3 min C-peptide (0.92 +/- 0.17 nM) lower (P < 0.001) than control subjects but higher (P < 0.05) than type I diabetic patients (0.53 +/- 0.11 nM). ...

At diagnosis, type II diabetic patients with ICA showed a 1 + 3 min C-peptide (0.92 +/- 0.17 nM) lower (P < 0.001) than control su

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A. Hagopian WA, et al. Among authors: gottsater a. J Clin Invest. 1993 Jan;91(1):368-74. doi: 10.1172/JCI116195. J Clin Invest. 1993. PMID: 8423232 Free PMC article.
Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM.
Gottsäter A, Ahmed M, Lilja B, Fernlund P, Sundkvist G. Gottsäter A, et al. Diabetes Care. 1996 Jan;19(1):60-3. doi: 10.2337/diacare.19.1.60. Diabetes Care. 1996. PMID: 8720536
Urinary albumin excretion was evaluated in a subset of 12 NIDDM patients with ICA at diagnosis (age 60 +/- 4 years) and 82 NIDDM patients without ICA at diagnosis (age 61 +/- 1 year). ...CONCLUSIONS: ICA at diagnosis of NIDDM is a marker of more favorable cardiovasc …
Urinary albumin excretion was evaluated in a subset of 12 NIDDM patients with ICA at diagnosis (age 60 +/- 4 years) and 82 NIDDM pati …
Proinsulin secretion during the first 3 years after diagnosis in diabetic patients with and without islet cell antibodies.
Gottsäter A, Owens DR, Luzio S, Sundkvist G. Gottsäter A, et al. Diabetes Care. 1996 Jun;19(6):659-62. doi: 10.2337/diacare.19.6.659. Diabetes Care. 1996. PMID: 8725869
Intraplatelet cyclic 3'-5' guanosine monophosphate is related to serum cholesterol.
Anwaar I, Gottsäter A, Wallmark A, Hedblad B, Lindgärde F, Mattiasson I. Anwaar I, et al. Among authors: gottsater a. Int Angiol. 1996 Sep;15(3):201-6. Int Angiol. 1996. PMID: 8971576
Intraplatelet cGMP was determined by radioimmunoassay and related to age, BMI, blood pressure, antihypertensive treatment, total, LDL and HDL cholesterol, triglycerides, blood glucose, HbA1c, smoking habit and intimal thickness of the common carotid artery in 265 subjects partici …
Intraplatelet cGMP was determined by radioimmunoassay and related to age, BMI, blood pressure, antihypertensive treatment, total, LDL and HD …
Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years.
Wroblewski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist G. Wroblewski M, et al. Among authors: gottsater a. Diabetes Care. 1998 Feb;21(2):250-5. doi: 10.2337/diacare.21.2.250. Diabetes Care. 1998. PMID: 9539991
RESEARCH DESIGN AND METHODS: Two hundred fifty-nine consecutive patients (aged 40-75 years) with newly suspected diabetes diagnosed during a 2-year period were studied. ...The frequency of obesity was estimated using two different sets of criteria: 1) National Diabetes Dat …
RESEARCH DESIGN AND METHODS: Two hundred fifty-nine consecutive patients (aged 40-75 years) with newly suspected diabetes diagnosed during …
197 results
Jump to page
Feedback